17.01.2020
- Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
21.10.2019
- In another move to reduce debt after buying Shire early this year, Japanese drugmaker Takeda has agreed to sell roughly 30 prescription pharmaceuticals and over-the-counter (OTC)...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
13.05.2019
- To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...
06.12.2018
- Shareholders of Japanese drugmaker Takeda and Netherlands-domiciled, US-managed Shire have separately approved the merger of the two pharmaceutical manufacturers. All regulatory...
23.11.2018
- European regulators have approved Takeda’s proposed acquisition of its US rival Shire, clearing the way for the £46 billion deal to complete. The clearance is conditional on both...
01.11.2018
- Japanese drugmaker Takeda has confirmed it is talking to the European Commission about selling Shire’s inflammatory bowel disease candidate SHP647, along with some associated...
